Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00535002 · ClinicalTrials.gov registry record · Phase 2
The Effect of Yohimbine on Cocaine Cue Reactivity
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 112
- Enrollment target
NCT00535002 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 112 participants.
The verdict
NCT00535002, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 112 participants
- Enrollment target
Study Summary
Stress and cues reminiscent of cocaine use promote craving and relapse in cocaine dependent individuals. In addition, there appears to be gender differences in determinants of relapse to drug use following abstinence in cocaine-dependent individuals. Therefore the purpose of the present study is to study the role of hormonal status on the response to cocaine-related cues with or without stress in cocaine-dependent women and men.
Interventions
- DRUG Placebo
- DRUG Yohimbine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2007-09 |
| Est. Completion | 2012-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00535002
The ClinicalTrials.gov registry entry for NCT00535002 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00535002 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00535002 about?
NCT00535002 is a clinical study titled "The Effect of Yohimbine on Cocaine Cue Reactivity". Stress and cues reminiscent of cocaine use promote craving and relapse in cocaine dependent individuals. In addition, there appears to be gender differences in determinants of relapse to drug use following abstinence in cocaine-dependent individuals. Therefore the purpose of the present study is to ...
What is the current status of trial NCT00535002?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 112 participants. The study started on 2007-09. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00535002?
The interventions under investigation include: Placebo (DRUG), Yohimbine (DRUG).
Who is sponsoring clinical trial NCT00535002?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.